The use of direct oral anticoagulants for primary thromboprophylaxis in ambulatory cancer patients: Guidance from the SSC of the ISTH

Venous thromboembolism (VTE) is a major complication in cancer patients. The Scientific and Standardization Committee through its subcommittee Hemostasis & Malignancy of the International Society for Thrombosis and Hemostasis (ISTH) aims to review emerging data on primary VTE prophylaxis with direct oral anticoagulants (DOACs) for ambulatory cancer patients and provide guidance to clinicians. A guidance document was previously published focusing...